Q1 2026 Holdings
Filed 2026-05-18 | 311 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $155.2M | 1,394,019 | 9.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $104.8M | 994,119 | 6.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $91.0M | 3,285,906 | 5.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $66.5M | 2,679,010 | 3.9% |
| State STR Spdr S&P 500 ETF T(SPY) | TR UNIT | 78462F103 | $49.4M | 75,940 | 2.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $48.2M | 914,699 | 2.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $41.7M | 632,556 | 2.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $41.4M | 1,139,331 | 2.4% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $39.2M | 337,125 | 2.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $35.9M | 1,871,455 | 2.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $34.5M | 1,446,375 | 2.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $26.8M | 1,425,367 | 1.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $26.2M | 1,089,818 | 1.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $24.6M | 2,744,714 | 1.4% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $21.2M | 1,012,866 | 1.2% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $21.0M | 3,789,132 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $20.9M | 405,197 | 1.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $20.0M | 407,273 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $18.4M | 211,450 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $17.1M | 338,323 | 1.0% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $16.0M | 3,410,190 | 0.9% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $15.4M | 1,581,443 | 0.9% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $15.3M | 316,939 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $15.1M | 259,137 | 0.9% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $14.5M | 264,278 | 0.9% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $14.1M | 3,133,175 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $13.9M | 1,000,604 | 0.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.6M | 427,816 | 0.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $13.3M | 2,979,429 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.3M | 228,899 | 0.8% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $13.1M | 524,441 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $13.0M | 133,893 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $12.9M | 329,540 | 0.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $12.6M | 185,699 | 0.7% |
| Spdr Series Trust(BIL) | STATE STREET SPD | 78468R663 | $12.4M | 135,585 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $12.1M | 213,473 | 0.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $12.1M | 1,582,987 | 0.7% |
| Inventiva SA(IVA) | ADS | 46124U107 | $12.1M | 2,174,398 | 0.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $12.0M | 160,338 | 0.7% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $11.6M | 161,252 | 0.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.1M | 6,606,572 | 0.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $10.9M | 1,361,536 | 0.6% |
| Terns Pharmaceuticals Inc(TERN)Call | COM | 880881107 | $10.5M | 200,000 | 0.6% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $10.3M | 1,000,000 | 0.6% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $10.1M | 4,544,113 | 0.6% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $10.1M | 2,434,941 | 0.6% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $9.4M | 12,154 | 0.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $8.5M | 457,137 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $8.4M | 1,467,350 | 0.5% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $8.4M | 1,849,004 | 0.5% |